Skip to main content
Figure 5 | Malaria Journal

Figure 5

From: Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling

Figure 5

Predicted artemether-lumefantrine treatment outcome per age group (in years) in an African population of 10,000 individuals dosed by (A) age or (B) weight when the IC 50 of artemether and dihydroartemisinin are 10-fold increased and the IC 50 of lumefantrine is 50-fold increased. Black triangles indicate the cut-off points of the age-based dosing bands.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us